KLHDC2
Basic information
Region (hg38): 14:49768130-49786385
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLHDC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 10 | |||||
Total | 0 | 1 | 23 | 1 | 1 |
Variants in KLHDC2
This is a list of pathogenic ClinVar variants found in the KLHDC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-49768487-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
14-49768561-G-C | not specified | Uncertain significance (May 18, 2022) | ||
14-49768604-G-A | not specified | Uncertain significance (May 05, 2023) | ||
14-49771650-C-G | not specified | Uncertain significance (Jul 05, 2023) | ||
14-49771655-A-G | not specified | Uncertain significance (Jun 09, 2022) | ||
14-49777890-A-G | not specified | Uncertain significance (Jan 08, 2024) | ||
14-49778486-A-G | not specified | Uncertain significance (Dec 15, 2022) | ||
14-49779635-C-T | not specified | Uncertain significance (May 31, 2023) | ||
14-49779655-G-A | not specified | Uncertain significance (Nov 19, 2022) | ||
14-49779773-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
14-49780214-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
14-49780256-C-G | not specified | Uncertain significance (Dec 15, 2022) | ||
14-49782395-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
14-49782593-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
14-49782879-T-C | not specified | Uncertain significance (May 17, 2023) | ||
14-49782884-C-A | not specified | Uncertain significance (Oct 12, 2021) | ||
14-49784672-C-A | Likely benign (Dec 01, 2022) | |||
14-49784706-T-C | Inborn genetic diseases | Uncertain significance (Oct 27, 2022) | ||
14-49784952-T-C | NEMF-related disorder | Benign (Dec 31, 2019) | ||
14-49784959-G-A | Inborn genetic diseases | Uncertain significance (Nov 18, 2022) | ||
14-49784975-G-A | Inborn genetic diseases | Uncertain significance (Jun 04, 2021) | ||
14-49784976-C-T | Inborn genetic diseases | Uncertain significance (Jun 04, 2021) | ||
14-49784977-A-G | Inborn genetic diseases | Uncertain significance (Jun 13, 2023) | ||
14-49785262-G-A | Inborn genetic diseases | Uncertain significance (Mar 24, 2023) | ||
14-49785298-GTCAAAGAA-G | Intellectual developmental disorder with speech delay and axonal peripheral neuropathy | Likely pathogenic (May 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLHDC2 | protein_coding | protein_coding | ENST00000298307 | 13 | 15584 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0265 | 0.973 | 125690 | 0 | 58 | 125748 | 0.000231 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.927 | 175 | 213 | 0.821 | 0.0000100 | 2660 |
Missense in Polyphen | 48 | 73.314 | 0.65472 | 874 | ||
Synonymous | 1.35 | 57 | 71.5 | 0.797 | 0.00000350 | 724 |
Loss of Function | 3.41 | 8 | 27.2 | 0.294 | 0.00000128 | 333 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000159 | 0.000155 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00115 | 0.00114 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000260 | 0.000255 |
Middle Eastern | 0.00115 | 0.00114 |
South Asian | 0.0000660 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Represses CREB3-mediated transcription by interfering with CREB3-DNA binding. {ECO:0000269|PubMed:11384994}.;
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- loftool
- rvis_EVS
- -0.76
- rvis_percentile_EVS
- 13.33
Haploinsufficiency Scores
- pHI
- 0.223
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.618
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.935
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Klhdc2
- Phenotype
- craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; vision/eye phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- Cellular component
- nucleus;nuclear body;nuclear membrane
- Molecular function